Clinical Trials Sponsored by Everest Medicines

Total 13807 results

Gilead Sciences
Everest Medicines

Active, not recruiting

Study of Sacituzumab Govitecan-hziy (IMMU-132) Versus Treatment of Physician's Choice in Participants With Metastatic or Locally Advanced Unresectable Urothelial Cancer (TROPiCS-04)

Locally Advanced or Metastatic Unresectable Urothelial Cancer

United States, Belgium, France, Spain, United Kingdom, Korea, Republic of, Czechia, Germany, Israel, China, Italy, Australia, Hong Kong, Taiwan, Portugal, Singapore, Croatia, Greece, Turkey, Sweden, Switzerland, Canada, Austria, Bulgaria and more
Everest Medicines (Singapore) Pte. Ltd.

Active, not recruiting

Efficacy and Safety in Chinese Patients With Immunoglobulin A Nephropathy (IgAN) Who Have Completed Study Nef-301

Primary Immunoglobulin A Nephropathy (IgAN)

China
Everest Medicines (China) Co.,Ltd.

Recruiting

Evaluate The Efficacy, Safety, Pharmacokinetics And Pharmacodynamics Of EVER001

Primary Membranous Nephropathy

China
Everest Medicines (Singapore) Pte. Ltd.

Not yet recruiting

Booster Study of PTX-COVID19-B in Adults Aged 18 Years and Older

SARS-CoV-2 Infection
Everest Medicines (Singapore) Pte. Ltd.

Not yet recruiting

Booster Superiority Study of PTX-COVID19-B Compared to Vaxzevria® in Adults Aged 18 Years and Older

SARS-CoV-2 Infection
EVEREST PESQUISA E DESENVOLVIMENTO LTDA

Not yet recruiting

Safety and Efficacy Evaluation of Insight GS Growing System

Early Onset Scoliosis (EOS)

Brazil
Everist Genomics, Inc

Completed

Vascular Reactivity Assessment by the AngioDefender Device -- A Precision Study

Cardiovascular Diseases

Canada
Everist Genomics, Inc

Completed

AngioDefender Versus Brachial Artery Ultrasound Imaging

Cardiovascular Diseases

United States, Canada
Everist Genomics, Inc

Completed

Brachial Artery Ultrasound Imaging: A Repeatability Study

Cardiovascular Diseases

United States
Everett Meyer

Completed

Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders

Leukemia, Myeloid | Myeloproliferative Disorders | Anemia | Neural Tube Defects | Myelodysplastic Syndromes (MDS) | Bone Marrow Transplant Failure

United States
EverEx Inc.

Not yet recruiting

A Confirmatory Trial of Multidisciplinary Digital Therapeutics for Patellofemoral Pain Syndrome

Patellofemoral Pain Syndrome

Korea, Republic of
EverEx Inc.

Active, not recruiting

Multidisciplinary Digital Therapeutics of Patellofemoral Pain Syndrome Versus Usual Care

Patellofemoral Pain Syndrome

Korea, Republic of
EverEx Inc.

Recruiting

Multidisciplinary Digital Therapeutics of Chronic Lower Back Pain Versus Usual Care

Chronic Low-back Pain

Korea, Republic of
Everett Meyer
National Cancer Institute (NCI)

Withdrawn

Donor Regulatory T Cells in Treating Patients With Visceral Acute Graft-versus-Host Disease After Stem Cell Transplant

Graft Versus Host Disease

United States
Everett Meyer
Doris Duke Charitable Foundation

Terminated

Haploidentical Allogeneic Transplant With Post-transplant Infusion of Regulatory T-cells

Chronic Lymphocytic Leukemia (CLL) | Acute Lymphoblastic Leukemia (ALL) | Myelodysplastic Syndrome (MDS) | Acute Myelogenous Leukemia (AML) | Leukemia, Acute | Chronic Myelogenous Leukemia (CML) | Non-Hodgkin Lymphoma (NHL)

United States
Angion Biomedica Corp
CTI Clinical Trial and Consulting Services; Everest Clinical Research; Clinical...

Active, not recruiting

Study to Prevent Acute Kidney Injury After Cardiac Surgery Involving Cardiopulmonary Bypass

Acute Kidney Injury

United States, Georgia, Canada, Brazil
Everett Meyer
National Heart, Lung, and Blood Institute (NHLBI)

Active, not recruiting

Combined Blood Stem Cell and Kidney Transplant of One Haplotype Match Living Donor Pairs.

ESRD

United States
University of Idaho
CJ Brush; Jayme Baker; Sydney Leverett

Not yet recruiting

Can a Novel Manual Therapy Technique Help Relieve Stress? Assessing Effects of Primal Reflex Release on the Body's Stress Response

Psychological Stress

United States
Hazel Everitt
National Institute for Health Research, United Kingdom

Completed

Management of Irritable Bowel Syndrome in Primary Care (MIBS Trial) (MIBS)

Irritable Bowel Syndrome

United Kingdom
Everett Meyer
National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...

Completed

Phase 1-2 MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T Cell

Lymphoma, Non-Hodgkin | Acute Myeloid Leukemia | Acute Leukemia | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | Myelodysplastic Syndromes (MDS) | Acute Lymphoblastic Leukemia (ALL) | Myeloid Leukemia, Chronic | Myeloproliferative Syndrome

United States
Mark Evers
National Cancer Institute (NCI)

Recruiting

TVB 2640 for Resectable Colon Cancer Other Resectable Cancers; a Window Trial.

Colon Cancer

United States
Medgar Evers College, The City University of New...

Not yet recruiting

The Influence of Sound on Stress, Anxiety, and Mood

Healthy
Medicines for Malaria Venture
Institute of Tropical Medicine, University of Tuebingen

Completed

DSM265 Chemoprophylaxis of Plasmodium Falciparum Malaria

Plasmodium Falciparum, Malaria

Germany
Totus Medicines

Recruiting

A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With Select Solid Tumors

Cervical Cancer | Gastric Cancer | Colorectal Cancer | Ovarian Cancer | Squamous Cell Carcinoma of Head and Neck | Endometrial Cancer | Non-small Cell Lung Cancer | Urothelial Carcinoma | HER2-negative Breast Cancer

United States
3D Medicines

Active, not recruiting

Study of 3D189 in Patients With Hematologic Malignancies

Multiple Myeloma | Non-Hodgkin Lymphoma | Acute Leukemia | Higher-risk Myelodysplastic Syndrome

China
3D Medicines

Completed

Phase 1 Study of 3D229 in Healthy Subjects

Healthy Subject

China
Pfizer
London School of Hygiene and Tropical Medicine; Medicines for Malaria Venture

Terminated

Evaluate Azithromycin Plus Chloroquine And Sulfadoxine Plus Pyrimethamine Combinations For Intermittent Preventive Treatment Of Falciparum Malaria Infection In Pregnant Women In Africa

Intermittent Preventive Treatment In Pregnancy (IPTp)

Malawi, Benin, Kenya, Tanzania, Uganda
3D Medicines

Not yet recruiting

3D1002 in Combination With Oxycodone Hydrochloride Sustained-release Tablets in Patients With Moderate to Severe Cancer Pain

Cancer Pain
Tenet Medicines

Terminated

Efficacy and Safety of VB119 in Subjects With Minimal Change Disease (MCD) and Focal Segmental Glomerulosclerosis (FSGS)

Focal Segmental Glomerulosclerosis | Minimal Change Disease

United States
Tenet Medicines

Active, not recruiting

Efficacy and Safety of VB119 in Subjects With Membranous Nephropathy

Membranous Nephropathy

United States
Pfizer
Biostatistics, Preventive Medicinte Department, College of Medicine, Yonsei...

Completed

Rheumatoid Arthritis Satisfaction Outcome Research

Rheumatoid Arthritis

Korea, Republic of
3D Medicines (Sichuan) Co., Ltd.

Recruiting

Phase I Trial of Envafolimab for Healthy Male Subjects

Healthy Male

China
3D Medicines (Sichuan) Co., Ltd.

Recruiting

Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors

Renal Cell Carcinoma | Hepatocellular Carcinoma | Non-small Cell Lung Cancer | Solid Tumors

China
3D Medicines (Sichuan) Co., Ltd.

Recruiting

ENVAFOLIMAB Single-agent Treatment in Patients With Advanced Solid Tumors

Solid Tumor

China
3D Medicines (Sichuan) Co., Ltd.

Recruiting

KN035 for dMMR/MSI-H Advanced Solid Tumors

Solid Tumor

China
3D Medicines (Sichuan) Co., Ltd.

Recruiting

Programmed Death Ligand (PD-L1) Combined With Chemotherapy for Patients With BTC (KN035-BTC)

Biliary Tract Neoplasms

China
3D Medicines (Beijing) Co., Ltd.

Active, not recruiting

A Monotherapy in Subjects With Advanced Solid Tumors

Solid Tumor, Adult

China, United States
3D Medicines (Sichuan) Co., Ltd.

Recruiting

Study of Envafolimab Alone or With Lenvatinib in Patients With Advanced Endometrial Cancer

Advanced Endometrial Cancer

China
3D Medicines (Sichuan) Co., Ltd.

Not yet recruiting

Multicenter Phase 2 Study of Envafolimab in Biliary Tract Cancers

Biliary Tract Neoplasms
3D Medicines (Beijing) Co., Ltd.

Withdrawn

3D011-08 Monotherapy in Subjects With Advanced Solid Tumors

Solid Tumor, Adult

China
3D Medicines (Sichuan) Co., Ltd.

Completed

Phase 1 Study of Anti-PD-L1 Monoclonal Antibody KN035 to Treat Locally Advanced or Metastatic Solid Tumors

Solid Tumors

United States
3D Medicines (Sichuan) Co., Ltd.

Recruiting

Phase III Study of Envafolimab Versus Placebo Plus Chemotherapy in Resectable Stage III NSCLC

Non-small Cell Lung Cancer

China
3D Medicines (Beijing) Co., Ltd.

Not yet recruiting

Efficacy and Safety of 3D185 Monotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Cholangiocarcinoma

Cholangiocarcinoma,Adult
3D Medicines (Sichuan) Co., Ltd.

Completed

Phase I Study of KN035 in Chinese Subjects With Advanced Solid Tumors

Solid Tumors

China
3D Medicines (Sichuan) Co., Ltd.

Completed

A Study of PD-L1 Antibody KN035 in Japanese Subjects With Locally Advanced or Metastatic Solid Tumors

Advanced or Metastatic Solid Tumors

Japan
Revolution Medicines, Inc.

Recruiting

Study of RMC-6291 in Combination With RMC-6236 in Participants With Advanced KRAS G12C Mutant Solid Tumors

Colorectal Cancer | Pancreatic Ductal Adenocarcinoma | Non-Small Cell Lung Cancer (NSCLC)

United States
Praxis Precision Medicines

Recruiting

Essential 3 - Decentralized, Phase 3 Study Evaluating the Safety and Efficacy of Ulixacaltamide in Essential Tremor (ET)

Essential Tremor

United States
Revolution Medicines, Inc.

Recruiting

Study of RMC-9805 in Participants With KRASG12D-Mutant Solid Tumors

Advanced Solid Tumors | Non-small Cell Lung Cancer (NSCLC) | Pancreatic Ductal Adenocarcinoma (PDAC) | Colorectal Cancer (CRC)

United States
Praxis Precision Medicines

Recruiting

A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies (DEE) (EMBOLD)

SCN2A Encephalopathy | SCN8A Encephalopathy

United States, Spain
TYK Medicines, Inc

Recruiting

Phase III Study of TY-9591 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (FLETEO)

NSCLC | EGFR Activating Mutation

China

Clinical Trials Sponsored by Everest Medicines

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Armenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations